Heart failure linked to Sutent treatment

NEW YORK (Reuters Health) - Kidney and stomach cancer patients given the chemotherapy drug Sutent (also called sunitinib), especially those with cardiac risk factors, need to be closely monitored for signs of heart trouble, results of a study confirm.

Continue to Heart failure linked to Sutent treatment on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz